Outcomes of postchemotherapy retroperitoneal lymph node dissection following high-dose chemotherapy with stem cell transplantation

Cancer

Volumn 121, Issue 24, 2015, Pages 4369-4375

  Cary, Clint ^a   Pedrosa, Jose A ^a   Jacob, Joseph ^a   Beck, Stephen D W ^a   Rice, Kevin R ^a   Einhorn, Lawrence H ^b   Foster, Richard S ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

germ cell tumor; high dose chemotherapy; outcomes; retroperitoneal lymph node dissection; surgery

Indexed keywords

CARBOPLATIN; CISPLATIN; ETOPOSIDE; IFOSFAMIDE; VINBLASTINE; ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; GAMMA KNIFE RADIOSURGERY; HIGH RISK PATIENT; HUMAN; INTERMEDIATE RISK PATIENT; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEMINOMA; STEM CELL TRANSPLANTATION; SURVIVAL TIME; TERATOMA; TREATMENT OUTCOME; FACTUAL DATABASE; INDUCTION CHEMOTHERAPY; LYMPH NODE; NEOPLASMS, GERM CELL AND EMBRYONAL; PATHOLOGY; RETROPERITONEUM; SALVAGE THERAPY; SURGERY; TESTICULAR NEOPLASMS;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DATABASES, FACTUAL; HUMANS; INDUCTION CHEMOTHERAPY; LYMPH NODE EXCISION; LYMPH NODES; MALE; NEOPLASMS, GERM CELL AND EMBRYONAL; RETROPERITONEAL SPACE; SALVAGE THERAPY; SEMINOMA; STEM CELL TRANSPLANTATION; TERATOMA; TESTICULAR NEOPLASMS;

EID: 84949318449     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.29678     Document Type: Article

References (13)

1. Einhorn LH, Williams SD, Chamness A, et al., High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors. N Engl J Med. 2007; 357: 340-348.
2. Beyer J, Kingreen D, Krause M, et al., Long term survival of patients with recurrent or refractory germ cell tumors after high dose chemotherapy. Cancer. 1997; 79: 161-168.
3. Bhatia S, Abonour R, Porcu P, et al., High-dose chemotherapy as initial salvage chemotherapy in patients with relapsed testicular cancer. J Clin Oncol. 2000; 18: 3346-3351.
4. Feldman DR, Sheinfeld J, Bajorin DF, et al., TI-CE high-dose chemotherapy for patients with previously treated germ cell tumors: results and prognostic factor analysis. J Clin Oncol. 2010; 28: 1706-1713.
5. Lotz JP, Bui B, Gomez F, et al., Sequential high-dose chemotherapy protocol for relapsed poor prognosis germ cell tumors combining two mobilization and cytoreductive treatments followed by three high-dose chemotherapy regimens supported by autologous stem cell transplantation. Results of the phase II multicentric TAXIF trial. Ann Oncol. 2005; 16: 411-418.
6. Kondagunta GV, Bacik J, Sheinfeld J, et al., Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors. J Clin Oncol. 2005; 23: 6549-6555.
7. Donohue JP, Leviovitch I, Foster RS, et al., Integration of surgery and systemic therapy: results and principles of integration. Semin Urol Oncol. 1998; 16: 65-71.
8. Spiess PE, Tannir NM, Tu SM, et al., Viable germ cell tumor at postchemotherapy retroperitoneal lymph node dissection: can we predict patients at risk of disease progression? Cancer. 2007; 110: 2700-2708.
9. Motzer RJ, Mazumdar M, Bosl GJ, et al., High-dose carboplatin, etoposide, and cyclophosphamide for patients with refractory germ cell tumors: treatment results and prognostic factors for survival and toxicity. J Clin Oncol. 1996; 14: 1098-1105.
10. Rick O, Bokemeyer C, Beyer J, et al., Salvage treatment with paclitaxel, ifosfamide, and cisplatin plus high-dose carboplatin, etoposide, and thiotepa followed by autologous stem-cell rescue in patients with relapsed or refractory germ cell cancer. J Clin Oncol. 2001; 19: 81-88.
11. Rick O, Bokemeyer C, Weinknecht S, et al., Residual tumor resection after high-dose chemotherapy in patients with relapsed or refractory germ cell cancer. J Clin Oncol. 2004; 22: 3713-3719.
12. Hendry WF, Norman AR, Dearnaley DP, et al., Metastatic nonseminomatous germ cell tumors of the testis: results of elective and salvage surgery for patients with residual retroperitoneal masses. Cancer. 2002; 94: 1668-1676.
13. Eggener SE, Carver BS, Loeb S, et al., Pathologic findings and clinical outcome of patients undergoing retroperitoneal lymph node dissection after multiple chemotherapy regimens for metastatic testicular germ cell tumors. Cancer. 2007; 109: 528-535.